Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Tissue Procurement For Hematolymphoid Conditions

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Who May Be Eligible (Plain English)

DISEASE CHARACTERISTICS: - Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: - Acute myeloid leukemia - Acute lymphoblastic leukemia - Chronic myelogenous leukemia - Chronic lymphoid leukemia - Non-Hodgkin lymphoma - Hodgkin lymphoma - Myelodysplastic syndromes - Myeloproliferative disorders - Multiple myeloma - Waldenstrom macroglobulinemia - Aplastic anemia - Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage - Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - Not specified Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
DISEASE CHARACTERISTICS: * Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: * Acute myeloid leukemia * Acute lymphoblastic leukemia * Chronic myelogenous leukemia * Chronic lymphoid leukemia * Non-Hodgkin lymphoma * Hodgkin lymphoma * Myelodysplastic syndromes * Myeloproliferative disorders * Multiple myeloma * Waldenstrom macroglobulinemia * Aplastic anemia * Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage * Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Treatments Being Tested

OTHER

biologic sample preservation procedure

All samples collected during routine clinical care.

OTHER

cytology specimen collection procedure

All Samples collected during routine clinical care.

Locations (1)

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States